Literature DB >> 16814659

Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction: implications for catheter ablation of atrial-pulmonary vein junction.

Alex Y Tan1, Hongmei Li, Sebastian Wachsmann-Hogiu, Lan S Chen, Peng-Sheng Chen, Michael C Fishbein.   

Abstract

OBJECTIVES: This study sought to examine the muscle connections and autonomic nerve distributions at the human pulmonary vein (PV)-left atrium (LA) junction.
BACKGROUND: One approach to catheter ablation of atrial fibrillation (AF) is to isolate PV muscle sleeves from the LA. Elimination of vagal response further improves success rates.
METHODS: We performed immunohistochemical staining on 192 circumferential venoatrial segments (32 veins) harvested from 8 autopsied human hearts using antibodies to tyrosine hydroxylase (TH) and choline acetyltransferase (ChAT).
RESULTS: Muscular discontinuities of widths 0.1 to 5.5 mm (1.1 +/- 1.0 mm) and abrupt 90 degrees changes in fiber orientation were found in 70 of 192 (36%) and 36 of 192 (19%) of PV-LA junctions, respectively. Although these anisotropic features were more common in the anterosuperior junction (p < 0.01), they were also present around the entire PV-LA junction. Autonomic nerve density was highest in the anterosuperior segments of both superior veins (p < 0.05 versus posteroinferior) and inferior segments of both inferior veins (p < 0.05 vs. superior), highest in the LA within 5 mm of the PV-LA junction (p < 0.01), and higher in the epicardium than endocardium (p < 0.01). Adrenergic and cholinergic nerves were highly co-located at tissue and cellular levels. A significant proportion (30%) of ganglion cells expressed dual adrenocholinergic phenotypes.
CONCLUSIONS: Muscular discontinuities and abrupt fiber orientation changes are present in >50% of PV-LA segments, creating significant substrates for re-entry. Adrenergic and cholinergic nerves have highest densities within 5 mm of the PV-LA junction, but are highly co-located, indicating that it is impossible to selectively target either vagal or sympathetic nerves during ablation procedures.

Entities:  

Mesh:

Year:  2006        PMID: 16814659     DOI: 10.1016/j.jacc.2006.02.054

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  84 in total

1.  Acute myocardial infarction induces bilateral stellate ganglia neural remodeling in rabbits.

Authors:  Bich Lien Nguyen; Hongmei Li; Michael C Fishbein; Shien-Fong Lin; Carlo Gaudio; Peng-Sheng Chen; Lan S Chen
Journal:  Cardiovasc Pathol       Date:  2011-10-14       Impact factor: 2.185

Review 2.  Autonomic nerves in pulmonary veins.

Authors:  Alex Y Tan; Peng-Sheng Chen; Lan S Chen; Michael C Fishbein
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

Review 3.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

4.  Sympathetic responses induced by radiofrequency catheter ablation of atrial fibrillation.

Authors:  Jian Cui; Mario D Gonzalez; Cheryl Blaha; Ashley Hill; Lawrence I Sinoway
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-12-07       Impact factor: 4.733

Review 5.  Role of the Auotnomic Nerves system in the Creation of Substrate for Atrial Fibrillation.

Authors:  Rishi Arora; Alan H Kadish
Journal:  J Atr Fibrillation       Date:  2008-12-01

6.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

7.  Epicardial injection of nanoformulated calcium into cardiac ganglionic plexi suppresses autonomic nerve activity and postoperative atrial fibrillation.

Authors:  Michael P O'Quinn; Kenneth J Dormer; Jose F Huizar; Kytai T Nguyen; Karoly Kaszala; Adam Sima; Kenneth A Ellenbogen; Alex Y Tan
Journal:  Heart Rhythm       Date:  2019-04       Impact factor: 6.343

8.  Cryoablation of stellate ganglia and atrial arrhythmia in ambulatory dogs with pacing-induced heart failure.

Authors:  Masahiro Ogawa; Alex Y Tan; Juan Song; Kenzaburo Kobayashi; Michael C Fishbein; Shien-Fong Lin; Lan S Chen; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2009-08-13       Impact factor: 6.343

9.  Effects of carvedilol on cardiac autonomic nerve activities during sinus rhythm and atrial fibrillation in ambulatory dogs.

Authors:  Eue-Keun Choi; Mark J Shen; Shien-Fong Lin; Peng-Sheng Chen; Seil Oh
Journal:  Europace       Date:  2014-01-26       Impact factor: 5.214

10.  Assessment of autonomic nervous system modulation after novel catheter ablation techniques for atrial fibrillation using multiple short-term electrocardiogram recordings.

Authors:  Satoshi Yanagisawa; Yasuya Inden; Aya Fujii; Yosuke Kamikubo; Yasunori Kanzaki; Monami Ando; Junya Funabiki; Yosuke Murase; Masaki Takenaka; Noriaki Otake; Yoshihiro Ikai; Yusuke Sakamoto; Rei Shibata; Toyoaki Murohara
Journal:  J Interv Card Electrophysiol       Date:  2017-11-06       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.